Portal de investigación
Success of the HR-NBL/SIOPEN local control trial strategy in high risk neuroblastoma patients undergoing high dose therapy with peripheral stem cell transplantation
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Ladenstein, R
- Poetscher, U
- Luksch, R
- Yaniv, I
- Papadakis, V
- Laureys, G
- Malis, J
- Balwierz, W
- Ruud, E
- Kogner, P
- Schroeder, H
- de Lacerda, AF
- Beck-Popovic, M
- Bician, P
- Garami, M
- Trahair, T
- Ambros, P
- Holmes, K
- Garaventa, A
- Michon, J
- Pearson, A
- Valteau-Couanet, D
- Gaze, M
- Botterberg, T
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Cita
Ladenstein,R,Poetscher,U,Luksch,R,Castel,V,Yaniv,I,Papadakis,V,Laureys,G et al. Success of the HR-NBL/SIOPEN local control trial strategy in high risk neuroblastoma patients undergoing high dose therapy with peripheral stem cell transplantation. 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT). 2018. Lisbon. CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND:SPRINGERNATURE. 2018 p.p. 128-129.